Clinical Trial Update: Nanocrystalline Megestrol Acetate in Concurrent Chemoradiotherapy for Locally Advanced Non-Small Cell Lung Cancer [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating nanocrystalline megestrol acetate combined with concurrent chemoradiotherapy for locally advanced non-small cell lung cancer, …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Nanocrystalline Megestrol Acetate (megestrol acetate)

Snippet

Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd. | Conditions: Non-small Cell Lung Cancer | Phase 3 | Status: RECRUITING